Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Usage of MicroRNA in Potential Therapeutics of Ewing?s Sarcoma

Irena Boulytcheva

MicroRNAs (miRs) have recently emerged as important regulators of intracellular gene expression. In miR, which is often dysregulated in cancer, sheds new light on the molecular mechanisms of carcinogenesis and is of great interest as a biomarker and new therapies and targets. Recently, many studies have investigated the miR biology of Ewing sarcoma. The results indicate that changes in miR expression are widespread in Ewing sarcoma, including both carcinogenic EWS / Ets fusion-dependent and independent mechanisms, and contribute to a malignant phenotype.MiRs with potential prognosis have been identified, and several preclinical studies suggest that miR manipulation may be therapeutically useful for this invasive disease.